Description
Breast Imaging Market—Forecast till 2027
Breast imaging Market Forecast
The breast imaging market is exceeded cross USD 6,810.80 million by 2027 to register a healthy CAGR of 8.38%. Breast imaging is a sub-strength of analytic radiology that includes imaging the breasts for screening or demonstrative purposes.
The development of the worldwide breast imaging market is driven by the elements like the rising predominance of breast disease, expanding commonness of the early location of tumors. Furthermore, the developing market for breast imaging sets out rewarding freedom for the market. Nonetheless, the related danger from radiation openness is probably going to limit the market development.
Breast imaging is a sub-division to the fame of symptomatic radiology that includes imaging the bosoms for screening or analytic purposes. The development of the worldwide breast imaging market is driven by the variables like the rising commonness of bosom malignancy, expanding pervasiveness of early location of diseases.
Additionally, the developing business sector for breast imaging sets out rewarding freedom for the market. Besides, the related danger from radiation exposure is probably going to limit the market development.
Segment Overview
The global Breast imaging market has been classified into technology and end-user.
In terms of technology type, the global market has been classified into ionizing technology, non-ionizing technology, and others. The Ionizing technology segment is further classified into Mammography, molecular breast imaging (MBI) or Molecular breast-specific Gamma Imaging (BSGI), PET-CT, Contrast-Enhanced Spectral Mammography (CESM), and Cone-Beam Computed Tomography.
The Non-Ionizing Technology segment is further classified into Breast ultrasound, Breast MRI, Breast Thermography, Optical Imaging, Microwave Imaging, Electrical Impedance Imaging (EII), and Others. Based on the end-use segment the global breast imaging market has been divided into Hospitals and clinics, specialty centers, and others.
Regional market
North America ruled the worldwide breast malignancy imaging market inferable from different factors like the high pervasiveness of breast disease among ladies, rising mindfulness about breast disease, innovative progressions, and the presence of significant makers in the area. Breast malignancy patients are expanding in the US and Canada.
It is the most normal malignancy found in American ladies, and the normal danger of creating breast disease in ladies in the US is around 13% in their life.
As indicated by the American Cancer Society, it is assessed that for breast disease in the United States in 2021, around 281,550 new instances of obtrusive breast malignancy will be analyzed in ladies, around 49,290 new instances of ductal carcinoma in situ (DCIS) will be analyzed, and around 43,600 ladies will pass on from breast disease. As indicated by the Canadian Cancer Society, in 2019, breast malignancy was the subsequent driving reason for death from disease in Canadian ladies.
Europe likewise has developed as an unmistakable market for breast imaging with an expanding commonness of breast cancer and grounded medical services foundation.
Key Competitors
The major players operating in the global Breast imaging market are Koninklijke Philips NV (Netherlands), General Electric Company (US), Siemens (Germany), Fujifilm Holdings Corporation (Japan), Hologic, Inc. (US), Delphinus Medical Technologies, Inc. (US), SonoCiné (US), CMR , aviscan Corporation (US), Planmed Oy (Finland), and KUB Technologies (US).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries.
Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
Related reports:
Imaging CRO Market – A Global and Regional Analysis: Focus on Services, Modalities, Applications, Phases, End User, Country Data (11 Countries), and Competitive Landscape – Analysis and Forecast, 2020-2031
Global AI-Enabled X-Ray Imaging Solutions Market: Focus on Product Type, Workflow, Mode of Deployment, and Application, and 10 Country-Level Data – Analysis and Forecast, 2021-2031
Global Hyperspectral Imaging in Agriculture Market: Focus on Product, Application, and Country Analysis – Analysis and Forecast, 2020-2026
Medical Device Connectivity Market: Market Segments: By Product & Service (Medical Device Connectivity Solutions and Medical Device Connectivity Services); By Technology (Wired Technologies, Wireless Technologies and Hybrid Technologies); By End User (Hospitals, Home Healthcare Centers, Diagnostic and Imaging Centers and Ambulatory Care Centers); and Region- Global Analysis of Market Size, Share & Trends for 2014- 2020 and Forecasts to 2030
Table of Contents
LIST OF CONTENTS
1 EXECUTIVE SUMMARY 14
2 MARKET INTRODUCTION 15
2.1 SCOPE OF THE STUDY 15
2.2 RESEARCH OBJECTIVE 15
2.3 MARKET STRUCTURE 15
2.4 ASSUMPTIONS & LIMITATIONS 16
3 RESEARCH METHODOLOGY 17
3.1 DATA MINING 17
3.2 SECONDARY RESEARCH 18
3.3 PRIMARY RESEARCH 18
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 19
3.5 FORECASTING TECHNIQUES 20
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21
3.6.1 BOTTOM-UP APPROACH 21
3.6.2 TOP-DOWN APPROACH 22
3.7 DATA TRIANGULATION 22
3.8 VALIDATION 23
4 MARKET DYNAMICS 24
4.1 OVERVIEW 24
4.2 DRIVERS 25
4.2.1 RISING PREVALENCE OF BREAST CANCER 25
4.2.2 INCREASING AWARENESS FOR EARLY DETECTION OF BREAST CANCER 25
4.2.3 RISING R&D INVESTMENT FOR BREAST CANCER 25
4.2.4 GROWING GERIATRIC POPULATION 26
4.3 RESTRAINTS 27
4.3.1 ASSOCIATED RISKS FROM RADIATION EXPOSURE 27
4.4 OPPORTUNITIES 28
4.4.1 EMERGING MARKETS OF BREAST IMAGING 28
4.4.2 TECHNOLOGICAL ADVANCEMENTS 28
5 MARKET FACTOR ANALYSIS 29
5.1 VALUE CHAIN ANALYSIS 29
5.1.1 R&D 30
5.1.2 MANUFACTURING 30
5.1.3 DISTRIBUTION AND SALES 30
5.1.4 POST-SALES MONITORING 30
5.2 PORTER’S FIVE FORCES MODEL 31
5.2.1 BARGAINING POWER OF SUPPLIERS 31
5.2.2 BARGAINING POWER OF BUYERS 31
5.2.3 THREAT OF NEW ENTRANTS 32
5.2.4 THREAT OF SUBSTITUTES 32
5.2.5 INTENSITY OF RIVALRY 32
5.3 IMPACT OF COVID-19 ON THE BREAST IMAGING MARKET 32
5.3.1 IMPACT ON DEMAND 32
5.3.2 IMPACT ON GROWTH 33
5.3.3 IMPACT ON GDP 33
5.3.4 IMPACT ON SUPPLY CHAIN 33
6 GLOBAL BREAST IMAGING MARKET, BY TECHNOLOGY 34
6.1 OVERVIEW 34
6.2 IONIZING TECHNOLOGY 36
6.2.1 MAMMOGRAPHY 37
6.2.1.1 DIGITAL MAMMOGRAPHY 38
6.2.1.2 3D MAMMOGRAM/3D BREAST TOMOSYNTHESIS 39
6.2.1.3 POSITRON EMISSION MAMMOGRAPHY(PEM) 39
6.2.1.4 ANALOG MAMMOGRAPHY 39
6.2.2 MOLECULAR BREAST IMAGING (MBI) 40
6.2.3 PET-CT 40
6.2.4 CONTRAST ENHANCED SPECTRAL MAMMOGRAPHY (CESM) 40
6.2.5 CONE-BEAM COMPUTED TOMOGRAPHY 41
6.3 NON-IONIZING TECHNOLOGY 41
6.3.1 BREAST ULTRASOUND 43
6.3.2 BREAST MRI 43
6.3.3 BREAST THERMOGRAPHY 43
6.3.4 MICROWAVE IMAGING 44
6.3.5 OPTICAL IMAGING 44
6.3.6 ELECTRIC IMPEDENCE IMAGING (EII) 44
6.4 OTHERS 45
7 GLOBAL BREAST IMAGING MARKET, BY END USER 46
7.1 OVERVIEW 46
7.2 HOSPITALS & CLINICS 47
7.3 SPECIALTY CENTERS 47
7.4 OTHERS 48
8 GLOBAL BREAST IMAGING MARKET, BY REGION 49
8.1 OVERVIEW 49
8.2 NORTH AMERICA 51
8.2.1 US 54
8.2.2 CANADA 56
8.3 EUROPE 58
8.3.1 GERMANY 61
8.3.2 FRANCE 63
8.3.3 UK 65
8.3.4 ITALY 67
8.3.5 SPAIN 69
8.3.6 REST OF EUROPE 71
8.4 ASIA-PACIFIC 73
8.4.1 CHINA 76
8.4.2 INDIA 78
8.4.3 JAPAN 80
8.4.4 SOUTH KOREA 82
8.4.5 AUSTRALIA 84
8.4.6 REST OF ASIA-PACIFIC 86
8.5 REST OF THE WORLD 89
8.5.1 MIDDLE EAST 92
8.5.2 AFRICA 94
8.5.3 LATIN AMERICA 96
9 COMPETITIVE LANDSCAPE 98
9.1 OVERVIEW 98
9.2 COMPETITIVE BENCHMARKING 99
9.3 MAJOR GROWTH STRATEGY IN THE BREAST IMAGING MARKET 100
9.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE BREAST IMAGING MARKET 101
9.5 KEY DEVELOPMENT ANALYSIS 101
9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 102
9.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL 102
9.6.2 MERGER/ ACQUISITION 103
9.6.3 EXPANSION/ INVESTMENT 103
9.7 FINANCIAL MATRIX 104
9.7.1 SALES, 2020 104
9.7.2 R&D EXPENDITURE 104
10 COMPANY PROFILES 105
10.1 KONINKLIJKE PHILIPS N.V. 105
10.1.1 COMPANY OVERVIEWS 105
10.1.2 FINANCIAL OVERVIEW 106
10.1.3 PRODUCTS/SERVICES OFFERED 107
10.1.4 KEY DEVELOPMENTS 107
10.1.5 SWOT ANALYSIS 108
10.1.6 KEY STRATEGIES 108
10.2 GENERAL ELECTRIC COMPANY 109
10.2.1 COMPANY OVERVIEW 109
10.2.2 FINANCIAL OVERVIEW 109
10.2.3 PRODUCTS/SERVICES OFFERED 110
10.2.4 KEY DEVELOPMENTS 110
10.2.5 SWOT ANALYSIS 111
10.2.6 KEY STRATEGIES 111
10.3 SIEMENS (SIEMENS HEALTHCARE GMBH) 112
10.3.1 COMPANY OVERVIEWS 112
10.3.2 FINANCIAL OVERVIEW 112
10.3.3 PRODUCTS/SERVICES OFFERED 113
10.3.4 KEY DEVELOPMENTS 113
10.3.5 SWOT ANALYSIS 114
10.3.6 KEY STRATEGIES 114
10.4 FUJIFILM HOLDINGS CORPORATION. 115
10.4.1 COMPANY OVERVIEWS 115
10.4.2 FINANCIAL OVERVIEW 115
10.4.3 PRODUCTS/SERVICES OFFERED 116
10.4.4 KEY DEVELOPMENTS 116
10.4.5 SWOT ANALYSIS 117
10.4.6 KEY STRATEGIES 117
10.5 HOLOGIC, INC. 118
10.5.1 COMPANY OVERVIEWS 118
10.5.2 FINANCIAL OVERVIEW 118
10.5.3 PRODUCTS/SERVICES OFFERED 119
10.5.4 KEY DEVELOPMENTS 119
10.5.5 SWOT ANALYSIS 120
10.5.6 KEY STRATEGIES 120
10.6 DELPHINUS MEDICAL TECHNOLOGIES, INC. 121
10.6.1 COMPANY OVERVIEW 121
10.6.2 FINANCIAL OVERVIEW 121
10.6.3 PRODUCTS/SERVICES OFFERED 121
10.6.4 KEY DEVELOPMENTS 121
10.6.5 SWOT ANALYSIS 122
10.6.6 KEY STRATEGIES 122
10.7 SONOCINÉ 123
10.7.1 COMPANY OVERVIEW 123
10.7.2 FINANCIAL OVERVIEW 123
10.7.3 PRODUCTS/SERVICES OFFERED 123
10.7.4 KEY DEVELOPMENTS 123
10.7.5 SWOT ANALYSIS 124
10.7.6 KEY STRATEGIES 124
10.8 CMR NAVISCAN CORPORATION 125
10.8.1 COMPANY OVERVIEW 125
10.8.2 FINANCIAL OVERVIEW 125
10.8.3 PRODUCTS/SERVICES OFFERED 125
10.8.4 KEY DEVELOPMENTS 125
10.8.5 SWOT ANALYSIS 126
10.8.6 KEY STRATEGIES 126
10.9 PLANMED OY 127
10.9.1 COMPANY OVERVIEWS 127
10.9.2 FINANCIAL OVERVIEW 127
10.9.3 PRODUCTS/SERVICES OFFERED 127
10.9.4 KEY DEVELOPMENTS 127
10.9.5 SWOT ANALYSIS 128
10.9.6 KEY STRATEGIES 128
10.10 KUB TECHNOLOGIES 129
10.10.1 COMPANY OVERVIEWS 129
10.10.2 FINANCIAL OVERVIEW 129
10.10.3 PRODUCTS/SERVICES OFFERED 129
10.10.4 KEY DEVELOPMENTS 129
10.10.5 SWOT ANALYSIS 130
10.10.6 KEY STRATEGIES 130
11 APPENDIX 131
11.1 REFERENCES 131
11.2 RELATED REPORTS 131
